Musculoskeletal Transplant Foundation

What Musculoskeletal Transplant Foundation does

Musculoskeletal Transplant Foundation, doing business as MTF Biologics, is a U.S. non-profit tissue bank founded in 1987 (circa 1985) by orthopedic surgeons and headquartered in Edison, New Jersey. The organization processes and distributes human allograft tissues for use in orthopedic surgery, plastic/aesthetic/reconstructive surgery, and soft tissue reconstruction/advanced wound repair. Its core processing methodology — described as the only 100% aseptic processing approach in the U.S. tissue-banking industry with no terminal radiation — is positioned as a structural differentiator, preserving natural tissue structure and biological properties for improved biocompatibility. Over nearly 40 years of operation, MTF reports distributing more than 12 million grafts without a single case of viral disease transmission.

MTF Biologics offers a portfolio spanning meniscal and fresh osteochondral allografts for orthopedics, reconstructive/aesthetic allografts (including soft tissue support and fat grafting), and wound-care allografts for diabetic foot ulcers, venous leg ulcers, sacral ulcers, tunneling wounds, and burn injuries; Flex HD is a featured human allograft product. A proprietary digital Graft Matching Platform enables orthopedic surgeons to upload films, receive instant confirmation, and request anatomically-matched grafts, reducing intraoperative modification time. The organization also operates a Professional Education/CME program and engages in patent activity around tissue processing and allograft preparation methods, recognized at the 2025 Edison Patent Awards.

The business model is transaction-fee allograft tissue distribution to healthcare professionals via direct sales in the United States and through an International Division's network of partners, agents, and distributors. Pricing is quote-based and not publicly disclosed. Joe Yaccarino serves as President & CEO. With 1,001–5,000 employees, MTF Biologics operates as one of the larger U.S. non-profit tissue banks, generating revenue through tissue distribution rather than donor or research fees, and reinvesting proceeds into research, partnerships, and grantmaking aligned with its patient-first mission.

Name

Musculoskeletal Transplant Foundation

Legal name

Musculoskeletal Transplant Foundation

Website

https://mtf.org

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Musculoskeletal Transplant Foundation (MTF Biologics) is a U.S. non-profit tissue bank that processes and distributes human allograft tissues to orthopedic, plastic/reconstructive, and wound-care surgeons via direct sales and an international partner network, using 100% aseptic processing with no terminal radiation.

Ownership category

akta.pro rank

Product category

Tissue Banking & Allograft Products

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

akta.pro secondary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

Keywords

• Human allograft tissues
• Tissue banking services
• Orthopedic allograft solutions
• Advanced wound care grafts
• Reconstructive surgery allografts

Headquarters

HQ city

Edison

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Allograft Tissue Distribution: Distribution of human allograft tissues for medical procedures including orthopedic surgery, plastic/reconstructive surgery, and wound care. Tissues are processed and distributed to healthcare professionals for clinical applications.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

MTF Biologics is a not-for-profit tissue bank that recovers, processes, and distributes human allograft tissues for use in orthopedic surgery, plastic/aesthetic/reconstructive surgery, and soft tissue reconstruction/advanced wound repair. The organization uses a proprietary 100% aseptic processing methodology with no terminal radiation to preserve the natural structure and biological properties of donor tissue, and provides a digital Graft Matching Platform to help surgeons request anatomically-matched allografts.

Product overview

MTF Biologics operates as a not-for-profit tissue bank offering a comprehensive portfolio of human allograft tissues and related services. The portfolio includes orthopedic allograft solutions (meniscal allografts, fresh osteochondral allografts), plastic/aesthetic/reconstructive surgery allografts, and soft tissue reconstruction/wound repair allografts. The company provides a proprietary Graft Matching Platform for digital ordering of anatomically-matched grafts. Products are processed using 100% aseptic processing with no terminal radiation to maintain tissue integrity. The company has distributed more than 12 million grafts over nearly 40 years of operation.

Differentiator

Problem solved

Functional benefit

Products and services

• Orthopedic Allograft Solutions Comprehensive allograft tissue solutions for orthopedic procedures including spinal surgery, meniscus repair, and sports medicine surgeries. Products include meniscal allografts and fresh osteochondral allografts, designed for orthopedic surgeons.
• Plastic, Aesthetic & Reconstructive Surgery Allografts Human allograft tissues for reconstructive surgeries and aesthetic procedures including soft tissue support, repair of congenital irregularities, and fat grafting. Tissues are aseptically processed to retain natural structure and biological properties, serving plastic, aesthetic and reconstructive surgeons.
• Soft Tissue Reconstruction & Advanced Wound Repair Allografts Portfolio of human allografts for coverage of soft tissue compromised by trauma, infection, surgical excision, and acute burn injuries. Designed for diabetic foot ulcers, venous leg ulcers, sacral ulcers, and tunneling wounds, serving wound care specialists and soft tissue reconstruction clinicians.
• Graft Matching Platform Fully-digital online ordering platform enabling orthopedic surgeons to request matched grafts. Surgeons can upload films, receive instant confirmation, and connect with the MTF team throughout the process for anatomically-matched allograft tissue such as large grafts, meniscal and fresh osteochondral allografts, eliminating extensive modifications during transplantation.
• Flex HD Human allograft tissue product featured in clinical studies for informational purposes. Referenced in MTF Biologics' professional education and medical use contexts.

Quantifiable outcome

• 12 million+ grafts distributed without a single case of viral disease transmission

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• International Partners, Agents, and DistributorscoreChannel Partner/ Reseller/ DistributorMTF Biologics maintains an extensive network of international partners, agents, and distributors to extend tissue donation services globally. This network is bolstered by relationships with leading global physicians, scientists, and tissue and organ recovery experts to achieve best-possible patient outcomes.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Organogenesis: Regenerative medicine company producing bio-active wound healing and surgical tissue products including allograft-derived offerings. Comparable in advanced wound care and surgical allograft positioning but focused on bioactive commercial product lines.
• MiMedx Group: Regenerative medicine company focused on allografts and placental tissue products for wound care, surgical recovery, and orthopedics. Comparable in allograft technology but commercially focused on emerging bioactive tissue applications.

Broad incumbents

• Arthrex: Private orthopedic surgical device company serving sports medicine and joint reconstruction surgeons with implants, instruments, and biologics. Comparable surgeon customer base (orthopedics, sports medicine) but focuses on devices rather than allografts.
• Stryker: Public medical technology giant with broad orthopedic, sports medicine, and surgical portfolios. Comparable in serving the same orthopedic surgeon customers but operates as a diversified device incumbent rather than a tissue bank.
• Integra LifeSciences: Public medical technology company offering regenerative tissue technologies and orthopedic products including dermal matrices and wound care. Overlaps with MTF in allograft/regenerative tissue segments but operates broader surgical portfolio.

Direct peers

• LifeNet Health: Non-profit organ and tissue procurement organization providing allograft tissues for orthopedic, cardiac, and wound healing applications. Directly comparable as a non-profit tissue bank with similar mission and surgeon-customer focus.
• RTI Surgical: For-profit developer of tissue-based implants and surgical grafts for orthopedic, spine, and sports medicine. Comparable in core allograft product lines and surgeon customers, though structured as a commercial enterprise rather than non-profit.
• Community Tissue Services: Non-profit tissue bank distributing allograft tissues across musculoskeletal, dental, and wound care specialties. Directly comparable in business model, portfolio breadth, and non-profit structure.
• Artivion (formerly CryoLife): Public medical device company specializing in tissue preservation and cardiac/vascular grafts, with growing orthopedics presence. Directly comparable as a tissue preservation and graft distribution company serving surgical specialists.
• AlloSource: Non-profit tissue bank offering allografts for orthopedic, spine, sports medicine, and wound care applications. Closest direct competitor to MTF in the U.S. non-profit tissue bank category with overlapping surgeon customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/MTFBiologics
• YouTubeyoutube.com/user/TheMTF1
• Facebookfacebook.com/MTFBiologics
• LinkedInlinkedin.com/company/musculoskeletal-transplant-foundation
• Instagraminstagram.com/mtfbiologics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Musculoskeletal Transplant Foundation